BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 35479267)

  • 1. Enhancing Palliative Care for Patients With Advanced Heart Failure Through Simple Prognostication Tools: A Comparison of the Surprise Question, the Number of Previous Heart Failure Hospitalizations, and the Seattle Heart Failure Model for Predicting 1-Year Survival.
    Blum M; Gelfman LP; McKendrick K; Pinney SP; Goldstein NE
    Front Cardiovasc Med; 2022; 9():836237. PubMed ID: 35479267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From statistical significance to clinical relevance: A simple algorithm to integrate brain natriuretic peptide and the Seattle Heart Failure Model for risk stratification in heart failure.
    AbouEzzeddine OF; French B; Mirzoyev SA; Jaffe AS; Levy WC; Fang JC; Sweitzer NK; Cappola TP; Redfield MM
    J Heart Lung Transplant; 2016 Jun; 35(6):714-21. PubMed ID: 27021278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting 1-Year Mortality in Outpatients With Heart Failure With Reduced Left Ventricular Ejection Fraction: Do Empiric Models Outperform Physician Intuitive Estimates? A Multicenter Cohort Study.
    Alba AC; Buchan TA; Saha S; Fan S; Demers C; Poon S; Mak S; Al-Hesayen A; Toma M; Zieroth S; Anderson K; Porepa L; Chih S; Giannetti N; Rac V; Levy WC; Ross HJ; Guyatt GH
    Circ Heart Fail; 2023 Jul; 16(7):e010312. PubMed ID: 37337896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of the Seattle Heart Failure Model in a community-based heart failure population and enhancement by adding B-type natriuretic peptide.
    May HT; Horne BD; Levy WC; Kfoury AG; Rasmusson KD; Linker DT; Mozaffarian D; Anderson JL; Renlund DG
    Am J Cardiol; 2007 Aug; 100(4):697-700. PubMed ID: 17697831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of Prognostic Risk Scores in Elderly Chinese Patients with Heart Failure.
    Cheng Y; Chai K; Zhu W; Wan Y; Liang Y; Du M; Li Y; Sun N; Yang J; Wang H
    Clin Interv Aging; 2021; 16():1669-1677. PubMed ID: 34556979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation and Recalibration of Seattle Heart Failure Model in Japanese Acute Heart Failure Patients.
    Shiraishi Y; Kohsaka S; Nagai T; Goda A; Mizuno A; Nagatomo Y; Sujino Y; Fukuoka R; Sawano M; Kohno T; Fukuda K; Anzai T; Shadman R; Dardas T; Levy WC; Yoshikawa T
    J Card Fail; 2019 Jul; 25(7):561-567. PubMed ID: 30099192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of the Surprise Question and the Development of a Multivariable Model.
    Davis M; Vanenkevort E; Young A; Wojtowicz M; Lagerman B; Gupta M; Adonizio C; Panikkar R
    J Pain Symptom Manage; 2023 May; 65(5):456-464. PubMed ID: 36736500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the Seattle heart failure model and cardiopulmonary exercise capacity for prediction of death in patients with chronic ischemic heart failure and intracoronary progenitor cell application.
    Honold J; DeRosa S; Spyridopoulos I; Fischer-Rasokat U; Seeger FH; Leistner D; Lotz S; Levy WC; Zeiher AM; Assmus B
    Clin Cardiol; 2013 Mar; 36(3):153-9. PubMed ID: 23377956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of the Seattle Heart Failure Model for palliative care referral in advanced ambulatory heart failure.
    Ng Fat Hing N; MacIver J; Chan D; Liu H; Lu YTL; Malik A; Wang VN; Levy WC; Ross HJ; Alba AC
    BMJ Support Palliat Care; 2018 Dec; ():. PubMed ID: 30523073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accuracy of Seattle Heart Failure Model and HeartMate II Risk Score in Non-Inotrope-Dependent Advanced Heart Failure Patients: Insights From the ROADMAP Study (Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients).
    Lanfear DE; Levy WC; Stehlik J; Estep JD; Rogers JG; Shah KB; Boyle AJ; Chuang J; Farrar DJ; Starling RC
    Circ Heart Fail; 2017 May; 10(5):. PubMed ID: 28465311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of the Seattle Heart Failure Model in patients with advanced heart failure.
    Kalogeropoulos AP; Georgiopoulou VV; Giamouzis G; Smith AL; Agha SA; Waheed S; Laskar S; Puskas J; Dunbar S; Vega D; Levy WC; Butler J
    J Am Coll Cardiol; 2009 Jan; 53(4):334-42. PubMed ID: 19161882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Surprise Question Can Be Used to Identify Heart Failure Patients in the Emergency Department Who Would Benefit From Palliative Care.
    Aaronson EL; George N; Ouchi K; Zheng H; Bowman J; Monette D; Jacobsen J; Jackson V
    J Pain Symptom Manage; 2019 May; 57(5):944-951. PubMed ID: 30776539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of renal dysfunction on the Seattle Heart Failure Model.
    Vakil KP; Dardas T; Dhar S; Moorman A; Anand I; Maggioni A; Linker DT; Mozaffarian D; Levy WC
    J Heart Lung Transplant; 2014 Feb; 33(2):163-9. PubMed ID: 24315784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surprise Question and Performance Status Indicate Urgency of Palliative Care Needs in Patients with Advanced Cancer at the Emergency Department: An Observational Cohort Study.
    Verhoef MJ; de Nijs EJM; Fiocco M; Heringhaus C; Horeweg N; van der Linden YM
    J Palliat Med; 2020 Jun; 23(6):801-808. PubMed ID: 31880489
    [No Abstract]   [Full Text] [Related]  

  • 15. Selecting patients for heart transplantation: comparison of the Heart Failure Survival Score (HFSS) and the Seattle heart failure model (SHFM).
    Goda A; Williams P; Mancini D; Lund LH
    J Heart Lung Transplant; 2011 Nov; 30(11):1236-43. PubMed ID: 21764604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiparametric prognostic scores in chronic heart failure with reduced ejection fraction: a long-term comparison.
    Agostoni P; Paolillo S; Mapelli M; Gentile P; Salvioni E; Veglia F; Bonomi A; Corrà U; Lagioia R; Limongelli G; Sinagra G; Cattadori G; Scardovi AB; Metra M; Carubelli V; Scrutinio D; Raimondo R; Emdin M; Piepoli M; Magrì D; Parati G; Caravita S; Re F; Cicoira M; Minà C; Correale M; Frigerio M; Bussotti M; Oliva F; Battaia E; Belardinelli R; Mezzani A; Pastormerlo L; Guazzi M; Badagliacca R; Di Lenarda A; Passino C; Sciomer S; Zambon E; Pacileo G; Ricci R; Apostolo A; Palermo P; Contini M; Clemenza F; Marchese G; Gargiulo P; Binno S; Lombardi C; Passantino A; Filardi PP
    Eur J Heart Fail; 2018 Apr; 20(4):700-710. PubMed ID: 28949086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incremental and independent value of cardiopulmonary exercise test measures and the Seattle Heart Failure Model for prediction of risk in patients with heart failure.
    Dardas T; Li Y; Reed SD; O'Connor CM; Whellan DJ; Ellis SJ; Schulman KA; Kraus WE; Forman DE; Levy WC
    J Heart Lung Transplant; 2015 Aug; 34(8):1017-23. PubMed ID: 25940075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Machine learning-based model for predicting 1 year mortality of hospitalized patients with heart failure.
    Tohyama T; Ide T; Ikeda M; Kaku H; Enzan N; Matsushima S; Funakoshi K; Kishimoto J; Todaka K; Tsutsui H
    ESC Heart Fail; 2021 Oct; 8(5):4077-4085. PubMed ID: 34390311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic impact of the addition of peak oxygen consumption to the Seattle Heart Failure Model in a transplant referral population.
    Levy WC; Aaronson KD; Dardas TF; Williams P; Haythe J; Mancini D
    J Heart Lung Transplant; 2012 Aug; 31(8):817-24. PubMed ID: 22759798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry.
    Canepa M; Fonseca C; Chioncel O; Laroche C; Crespo-Leiro MG; Coats AJS; Mebazaa A; Piepoli MF; Tavazzi L; Maggioni AP;
    JACC Heart Fail; 2018 Jun; 6(6):452-462. PubMed ID: 29852929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.